PRODUCTS

Catalog Number:RP0057
Recombinant Human/Mouse/Rat TGFB3
Copy Product Information

Size:

50 μg

500 μg

Price:

$704.00

$3050.00

Delivery: Order now, ship in 3 days

Product Details
Product Name Recombinant Human/Mouse/Rat TGFB3 Accesstion Number P10600
Alternative Names Transforming growth factor beta-3; TGFB3; TGF-beta-3; Latency-associated peptide; LAP
Description Recombinant Human/Mouse/Rat Transforming Growth Factor Beta 3 is produced by our Mammalian expression system and the target gene encoding Ala301-Ser412(Tyr340Phe) is expressed.
Calculated Molecular Weight Mol Mass:12.7 KDa; APMol Mass:12-14 KDa, reducing conditions Formulation Lyophilized from a 0.2 μm filtered solution of 50mM Glycine-HCl, 150mM NaCl, pH 2.5.
Endotoxin < 0.01 EU/µg as determined by LAL test. Purity Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Biological Activity Measured by its ability to inhibit the IL-4-dependent proliferation of TF-1 mouse T cells. The ED50 for this effect is 10-80 pg/ml. (QC verified)
Reconstitution Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
Storage Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below.
Background Transforming growth factor beta 3(TGFB3) is a member of a TGF -β superfamily which is defined by theirstructural and functional similarities. TGFB3 is secreted as a complex with LAP. This latent form of TGFB3becomes active upon cleavage by plasmin, matrix metalloproteases, thrombospondin -1, and a subset ofintegrins. It binds with high affinity to TGF- β RII, a type II serine/threonine kinase receptor. TGFB3 is involved incell differentiation, embryogenesis and development.It is believed to regulate molecules involved in cellularadhesion and extracellular matrix (ECM) formation during the process of palate development. Without TGF-β3,mammals develop a deformity known as a cleft palate.
  • Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
  • Measured by its ability to inhibit the IL-4-dependent proliferation of TF-1 mouse T cells. The ED50 for this effect is 10-80 pg/ml. (QC verified)